John is the Chief Technology Officer of the Financial Times. John joined the FT in 2002 for three years and rejoined again in 2012, becoming CTO in 2016. John has spent most of his career looking to achieve outcomes by blending data-driven analysis with qualitative insights and intelligence. His work is mostly but not exclusively all about the data.
Founder & CEO, Safe & The City
Jillian Kowalchuk is an award-winning entrepreneur, TEDx speaker and is the Founder & CEO of Safe & The City, the AI street-smarts app to safely navigate while making your experience count. She sits on the Commonwealth Businesswomen Executive Team to empower 1B girls and women into business and was awarded Most Inspiring Role Model by the 53 Commonwealth Governments. She sits on the Department for International Trade’s Global Entrepreneurial Programme Female Founders Advisory Board to help attract and retain international female talent to the U.K. Jillian is a TEDx speaker, business coach and consultant sharing her knowledge and experience of traveling to over 50 countries and a breadth of knowledge on gender equality, tech4good, women in STEM to inspire and motivate others to take innovative action to solve meaningful problems. Jillian is a founding member of FemTechTalks, which seeks to find practical methods women can overcome structural and internal barriers in tech. She holds a MSc in Public Health from London School of Hygiene & Tropical Medicine and BA in Psychology and currently resides in London.
Jamie is a full stack web developer and innovator for the Financial Times working in their Labs department. Jamie has been working as a developer for over 4 years. He studied Sociology and Politics at Sussex University and learned to code after leaving university.
Research and Development Graduate Scientist, AstraZeneca
Hannah joined AstraZeneca as a Research & Development Graduate Scientist in 2018 after receiving a Biochemistry degree from Oxford University. She has diverse scientific experience across molecular oncology, neuroscience, and quantitative biology. In her final placement on the graduate scheme, she will be gaining further experience in genome editing and drug resistance. She plans to pursue a PhD after completing the scheme.
More coming soon!